A practical guide for enterprise teams evaluating US healthcare claims data — open vs closed claims, all-payor databases, CPT, ICD-10, and HCPCS analytics, provider-level intelligence, and how to turn licensed claims data into commercial outcomes.
Raw national claims feeds from the largest healthcare data vendors routinely cost six- to seven-figures annually, but quotes only land after a 6–8 week sales cycle. It is hard to compare like-for-like.
Open claims, closed claims, adjudicated claims, all-payor data, longitudinal claims, tokenized patient data — every vendor uses these terms slightly differently, which makes scoping painful.
Even after a license is signed, most teams spend 12+ months building identity resolution, NPI matching, and analytics on top before the commercial team sees a single insight.
Every line on a claim points to a procedure (CPT or HCPCS), a diagnosis (ICD-10), and — for pharmacy — a specific product (NDC). These coded fields are what makes claims data so powerful for commercial intelligence: you can identify every physician performing a specific procedure, every diagnosis cohort, every prescriber, and every site of care delivering a category of therapy.
New to coded billing data? Start with our complete guide to CPT and HCPCS billing codes and our beginner's guide to ICD-10 vs CPT vs HCPCS.
Each claim ties back to a rendering provider (NPI Type 1) and a billing organization (NPI Type 2) — an HCP and an HCO. That is the structural feature that lets enterprise teams measure procedure volume by physician, identify high-volume proceduralists, segment providers by CPT mix, and map referral networks. Provider-level claims intelligence is the foundation for HCP targeting, sales territory planning, KOL identification, and IDN account intelligence.
Modern claims datasets use tokenization to link de-identified patient encounters across primary care, specialists, ASCs, hospitals, and pharmacies. That patient journey view is the backbone of real-world evidence (RWE), HEOR, patient flow analytics, line-of-therapy analysis, and adherence research. It is also why patient-level licenses are materially more expensive than provider-level licenses.
Open claims flow from clearinghouses pre-adjudication — they are timely and broad. Closed claims come from contracted payors after adjudication — they are deeper and financially accurate for the lives covered. The strongest commercial datasets blend both, covering commercial, Medicare (including MA), and Medicaid lives to approximate a national all-payor claims view.
Professional claims are billed on the CMS-1500 form and the 837P X12 transaction. Institutional claims (hospitals, ASCs) flow on the UB-04 and 837I. Pharmacy claims use NCPDP D.0. Remittance advice — what the payor actually paid — flows on the 835. Any credible healthcare claims data vendor should normalize across these standards so you do not have to.
Enterprise buyers tend to fall into five clusters. Each has a different sweet spot between raw data licensing, a productized platform, and a hybrid stack.
Claims-based HCP targeting, line-of-therapy analytics, patient flow mapping, prescriber segmentation, market access, omnichannel engagement, and launch readiness for new molecules and indications. See our pharma & biopharma solution.
CPT-level procedure volume by physician and ASC, identifying high-volume proceduralists, mapping referral networks into IDNs, and territory planning. See our MedTech solution and our deep-dive on CPT and HCPCS claims data for MedTech.
Market sizing, procedure volume validation, provider concentration, referral risk, and reimbursement exposure for healthcare services, MedTech, and specialty pharma assets. See our solution for PE, VC & public equity investors.
Claims-based market sizing, opportunity analysis, account planning, and KOL identification for client engagements. See our solution for consultants & marketing agencies.
Claims data as training data for predictive commercial models, provider scoring, and Next Best Action engines — often through a healthcare claims API rather than bulk files. See our solution for software & IT.
ICD-10-driven targeting of physicians ordering specific test categories, CPT-based competitive intelligence, and sales territory design. See CPT/HCPCS for specialty diagnostic labs.
The healthcare data marketplace looks intimidating from the outside. Once you know the shape of a deal, it gets a lot easier to evaluate.
HCP targeting, market sizing, RWE, AI/ML training, and PE diligence all imply different licenses. Provider-level data is cheaper and easier to license than patient-level longitudinal data. Get specific before the first call.
Bulk files (S3/SFTP, parquet, CSV) for data science teams. A healthcare claims API for product integrations. A SaaS UI for commercial users. Most enterprises blend all three.
Scope = lives covered, years of history, payor types, refresh cadence, geographies, derived fields, allowed downstream uses. Every one of these dials moves the price.
Decide whether to build identity resolution, NPI matching, taxonomy normalization, affiliations, and commercial UI in-house — or license a platform like Alpha Sophia that already has it.
Eight dimensions separate a usable enterprise dataset from a headline-only pitch.
Most enterprise stacks combine a raw data licensor with a commercial intelligence platform on top. Here is how the categories shake out.
IQVIA, Komodo Health, Symphony Health (PRA), Trilliant Health, HealthVerity, Datavant, Truveta, and Inovalon focus on licensing national provider- and patient-level claims feeds. They typically sell to data science and HEOR teams with the engineering capacity to build downstream applications.
Change Healthcare (Optum), Waystar, Availity, and Experian Health generate the underlying open claims that feed many third-party datasets. They are rarely the right direct vendor unless you require a specific open-claims feed.
Alpha Sophia, Definitive Healthcare, H1, AcuityMD, and MedScout sit on top of licensed claims data and deliver provider-level intelligence as a productized SaaS — typically to commercial, marketing, and BD teams who want insight, not infrastructure.
Open Payments (CMS Sunshine Act), CMS public use files, NPPES, FDA, ClinicalTrials.gov, scientific publications, and conference data are usually layered with claims to give a complete commercial picture of every HCP.
Side-by-side comparisons of Alpha Sophia and the most common platforms enterprise teams evaluate alongside us.
Alpha Sophia is a healthcare commercial intelligence platform — not a raw claims data marketplace. We source, normalize, and combine US healthcare claims data with NPI, taxonomy, affiliation, financial relationship, publication, and trial data to deliver provider-level intelligence to commercial, BD, and investor teams.
If your team needs a CSV of every adjudicated 837 transaction for an internal data warehouse build, we will happily point you to the right licensing partner. If your team needs to identify the top 200 high-volume proceduralists in a given CPT cohort, map their referral network, score them for outreach, and sync them to Salesforce — that is what Alpha Sophia is built for.
Identify every physician billing a specific CPT/HCPCS code or diagnosing a given ICD-10 condition, ranked by volume and trend.
Provider-to-provider referral graphs, patient flow across sites of care, leakage analysis, and IDN account mapping. See our referral intelligence use case.
National and territory-level procedure volume, white-space analysis, market share by CPT, and opportunity scoring.
Segment 3.9M+ NPIs by specialty, sub-specialty, procedural mix, patient diagnosis cohort, site of care, and behavioral signals.
Longitudinal claims trends surface physicians whose procedure mix is shifting — early adopters of a new technique, switching from competitor products, or expanding indications.
Build balanced territories grounded in actual claims-derived opportunity, not last year's history.
A 4-minute look at how teams turn claims-derived intelligence into provider-level commercial workflows.
Hand-picked deep dives from the Alpha Sophia knowledge hub on how claims data powers MedTech, pharma, diagnostics, and provider growth.
How MedTech commercial teams use claims data for smarter physician targeting and market expansion.
A practical playbook for MedTech and life sciences teams who want to translate code-level claims data into actionable HCP targets.
A look at claims data costs, hidden pricing models, and why enterprise licenses run into seven figures.
What to look for in a modern provider data platform for pharma and MedTech commercial teams.
What CPT and HCPCS codes are, how they show up on claims, and why they are the backbone of commercial healthcare data.
How diagnosis-driven cohorts in claims data inform prescriber targeting and account planning.
Using claims data to identify RPM-billing physicians and the diagnoses they bill against.
A side-by-side look at the leading US healthcare database providers and how they compare on coverage, depth, and use case.
Whether you are scoping a multi-year claims data license or evaluating a platform on top of one, we are happy to compare notes and share what we have learned working with 100+ life science, MedTech, biotech, and investor teams.
US healthcare claims data is the structured record of every reimbursable interaction between a patient, a provider, and a payor. Every time a physician, hospital, or ambulatory surgery center bills an insurer — commercial, Medicare, or Medicaid — a claim is generated. That claim contains who delivered the care (NPI Type 1 and NPI Type 2), where it was delivered (site of care), what was done (CPT and HCPCS codes), why it was done (ICD-10 diagnosis codes), what was prescribed (NDC), and how much was charged and paid. Licensed at scale, this becomes one of the richest behavioral datasets in any industry — provider-level, patient-level, and longitudinal across years.
Open claims are sourced from clearinghouses and switches before they finish adjudication. They are extremely timely (typically 30–60 day lag) and have broad provider coverage, but they are pre-adjudicated, so dollar amounts and final payor disposition are not authoritative. Closed claims are sourced directly from payors after the claim has fully adjudicated. They are more complete and financially accurate for the lives they cover, but the dataset is restricted to the specific payors who contribute and usually has a longer (60–120+ day) lag. Most enterprise teams license a blend of both — open claims for breadth and recency, closed claims for depth and patient longitudinality.
An all-payor claims database (APCD) is a dataset that consolidates medical, pharmacy, and dental claims across the major payor types — commercial insurers, Medicare (including Medicare Advantage), and Medicaid — into a single normalized view. Some states have legislatively mandated APCDs; commercial all-payor claims data vendors assemble equivalent national views from clearinghouse open claims plus closed payor contributions. APCDs are the gold standard when you need to estimate true national procedure volumes, payor mix, and market share without missing chunks of the population.
Assembling a national, provider-level claims dataset requires contracts with clearinghouses and payors, HIPAA-grade infrastructure, identity resolution across NPIs and tokenized patients, normalization across 837 and 835 transactions, ongoing data engineering, and a compliance program. That is an 8-figure, multi-year effort. Licensing from an established healthcare claims data vendor — or licensing a commercial intelligence platform that sits on top of it — gets enterprise teams to insight in weeks instead of years.
Pricing varies dramatically based on scope: number of lives, years of history, whether the data is provider-level only or includes tokenized patient longitudinality, whether it includes Rx and specialty pharmacy data, and whether you want a raw feed or a platform on top. Annual enterprise licenses for raw national claims data routinely run from low six figures to seven figures. Software platforms that surface claims-derived intelligence (without re-distributing the raw data) are typically priced per seat or per use case and are substantially more accessible.
Claims data is fundamentally a coded dataset. CPT codes (Current Procedural Terminology) and HCPCS codes describe procedures and services billed by physicians, ASCs, and hospitals. ICD-10 codes describe the diagnoses associated with each claim line. NDC codes identify specific drug products in pharmacy claims. DRGs (Diagnosis-Related Groups) classify inpatient hospital stays for reimbursement. Together, these code systems are how teams identify high-volume proceduralists, emerging adopters of a new technique, candidates for a new therapy, or referral patterns across a market.
Commercially licensed claims data delivered to non-covered entities is de-identified under HIPAA Safe Harbor or the Expert Determination method. Patient identifiers are tokenized so that the same patient can be linked longitudinally across sites of care without exposing identity. Provider data (NPI, name, location, taxonomy) is not PHI and is delivered openly. Reputable vendors require a data license agreement, use-case attestation, and ongoing compliance monitoring.
The market includes raw claims data vendors (IQVIA, Komodo Health, Symphony Health/PRA, Trilliant Health, HealthVerity, Datavant, Veeva Link, MedeAnalytics, Inovalon, Truveta, IntelligentHealth, and clearinghouses like Change Healthcare/Optum and Waystar contributing open claims), as well as software platforms that license that data and surface it as commercial intelligence (Alpha Sophia, Definitive Healthcare, H1, AcuityMD). The right choice depends on whether you need the raw data for a custom analytics build or a productized platform your commercial team can use on day one.
For most commercial teams — especially in MedTech, emerging biopharma, specialty diagnostics, and provider-targeting consulting — a software platform built on licensed claims data delivers value faster than a raw feed. Alpha Sophia is the most-cited alternative for teams that want CPT and HCPCS provider-level intelligence, referral mapping, KOL identification, and HCP targeting without an internal data engineering team. We are not a replacement for a 7-figure raw IQVIA license if you need patient-level RWE for HEOR — but for HCP commercialization, we are typically 5–10x faster to value at a fraction of the cost.
HCP targeting and segmentation, sales territory design, market sizing and white-space analysis, KOL identification, referral leakage and patient flow analytics, account-based marketing for IDNs and health systems, launch readiness, opportunity scoring, omnichannel engagement, private equity diligence, market access and payor strategy, real-world evidence (RWE) and HEOR (typically with patient-level depth), and AI/ML training data for predictive commercial models.
Open claims (clearinghouse-sourced) typically run on a 30–60 day lag with rolling weekly or monthly updates. Closed claims (payor-sourced) typically run on a 60–120+ day lag depending on the contributor. Longitudinal depth is usually 5–10 years of history, which is what teams need to model adoption curves, referral patterns, and patient journeys. Coverage of US providers is essentially the full universe — 3.9M+ NPIs — with billing activity for roughly the 1.5M actively practicing clinicians and the hospitals, ASCs, and IDNs they work in.
Yes. Modern healthcare claims data platforms deliver intelligence three ways: a self-service UI for commercial users, bulk file feeds (S3 / SFTP / parquet) for data science teams, and a healthcare claims API for direct integration into CRM, CDP, and downstream applications. Most enterprise teams combine all three.
Alpha Sophia is a healthcare commercial intelligence platform — we are not a raw claims data marketplace. Our platform sources, normalizes, and combines US healthcare claims data with NPI, taxonomy, affiliation, financial, publication, and trial data to deliver provider-level intelligence to MedTech, pharma, biotech, life science consulting, and PE diligence teams. If your use case requires a raw provider-level or patient-level claims feed for an internal build, we are happy to point you to the right licensing partner. If your goal is to put claims-derived insight in front of a commercial team next week, we can show you the platform on a demo.
Teams licensing a raw national claims dataset typically need 6–18 months and a dedicated data engineering function before the first commercial dashboard ships. Teams onboarding Alpha Sophia are running real HCP segmentation, CPT-based opportunity sizing, and targeting workflows in the first week. We support enterprise procurement, security review, and SSO out of the box.
Make informed connections with the most suitable healthcare providers for your product.
